DISEASE INDICATIONS: HIV/AIDS

MANUFACTURER: ViiV Healthcare

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Cabenuva is a complete and injectable regimen for the treatment of HIV-1 in adults. It utilizes cabotegravir and rilpivirine, two drugs that reduce the viral load in patients, preventing the spread of the virus.